ステント留置患者におけるLDL-Cと非HDL-Cの不調和と臨床転帰の間の関連

SHIIBA Michiyo; SHIIBA Michiyo; ZHANG Bo; MIURA Shin-ichiro; IKE Amane; NOSE Daisuke; NOSE Daisuke; KUWANO Takashi; IMAIZUMI Satoshi; SUGIHARA Makoto; IWATA Atushi; NISHIKAWA Hiroaki; KAWAMURA Akira; SHIRAI Kazuyuki; SHIRAI Kazuyuki; YASUNAGA Shin’ichiro; SAKU Keijiro

文献

J-GLOBAL ID：201802262977554076 整理番号：18A0412092

ステント留置患者におけるLDL-Cと非HDL-Cの不調和と臨床転帰の間の関連

Association between discordance of LDL-C and non-HDL-C and clinical outcomes in patients with stent implantation: from the FU-Registry

出版者サイト複写サービスで全文入手 {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=18A0412092&COPY=1") }}
高度な検索・分析はJDreamⅢで {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0412092&from=J-GLOBAL&jstjournalNo=X0101A") }}

著者 (17件)： , , , , , , , , , , , , , , , ,
資料名：
巻： 33 号： 2 ページ： 102-112 発行年： 2018年02月
JST資料番号： X0101A ISSN： 0910-8327 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：ドイツ (DEU) 言語：英語 (EN)

・ステント留置術後18か月まで留置が成功している患者801人...

,...
,...

続きはJDreamIII（有料）にて {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0412092&from=J-GLOBAL&jstjournalNo=X0101A") }}

循環系の臨床医学一般

引用文献 (30件)：

Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y (2006) Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 368:1155-1163
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Jr., Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, Group JS (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359:2195-2207
LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK, Treating to New Targets I (2005) Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352:1425-1435
Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M, Tsai J, and Incremental Decrease in End Points Through Aggressive Lipid Lowering Study G (2005) High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA 294:2437-2445
Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM, Pravastatin or Atorvastatin E, and Infection Therapy-Thrombolysis in Myocardial Infarction I (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350:1495-1504

, , ,

前のページに戻る